Bessemer Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-705
Closed -$379K 65
2023
Q3
$379K Buy
+705
New +$363K 0.52% 68
2020
Q2
Sell
-11,016
Closed -$1.53M 98
2020
Q1
$1.53M Hold
11,016
0.76% 25
2019
Q4
$1.45M Hold
11,016
0.57% 34
2019
Q3
$1.23M Hold
11,016
0.51% 37
2019
Q2
$1.22M Buy
+11,016
New +$1.3M 0.51% 37

Other funds holding LLY

Bessemer Securities's LLY Position: Q4 2023 in Review

Bessemer Securities sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 705 shares — an estimated $379K sold.

Bessemer Securities first reported a position in LLY in Q2 2019 and held it in 5 quarters. The position peaked at $1.53M in Q1 2020. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Bessemer Securities reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Bessemer Securities sold 705 Eli Lilly shares in Q4 2023, an estimated $379K.
  • Bessemer Securities first reported a position in Eli Lilly in Q2 2019 and held it in 5 quarters.
  • Bessemer Securities's Eli Lilly position peaked at $1.53M in Q1 2020.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Bessemer Securities's 13F filing for Q4 2023.